venoplant gdue biotrap argivit duonorm aurastop venoplant gdue biotrap argivit duonorm aurastop venoplant gdue biotrap argivit duonorm aurastop

Abioclav

Amoxicillin and clavulanic acid

Abioclav

Active substance

Amoxicillin and clavulanic acid

Strenght and pharmaceutical forms

875 mg+125 mg film-coated tablets - 12 tablets
400 mg+57 mg/5 ml powder for oral suspension - bottle 70 ml

ATC

J01CR02 - Combinations of penicillins, included beta-lactamase inhibitors

Therapeutic Indications

ABIOCLAV is indicated for the treatment of the following infections in adults and children:
• Acute bacterial sinusitis (adequately diagnosed)
• Acute otitis media
• Acute exacerbations of chronic bronchitis (adequately diagnosed)
• Community acquired pneumonia
• Cystitis
• Pyelonephritis
• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis
• Bone and joint infections, in particular osteomyelitis

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics - Abioclav


Products of the same therapeutic areas

Events

05/07/24

La chirurgia gastroenterologica high-tech: dall'integrazione tecnologica all'intelligenza artificiale

Maglie

"La chirurgia gastroenterologica high-tech: dall'integrazione tecnologica all'intelligenza artificiale"

 Download

28/06/2024

“SCENARI FUTURI IN EPATOLOGIA 2024”

SPOLETO (PG)

 

 Download